Ribose-Nucleic Acid (RNA)-Based Therapeutics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theRibose-Nucleic Acid (RNA)-Based Therapeutics Market?
The increasing prevalence of cancer is driving the growth of the ribose-nucleic acid (RNA)-based therapeutics market, as RNA therapies offer targeted solutions for complex genetic mechanisms. For example, in August 2023, the Australian Institute of Health and Welfare stated that 151,000 people were diagnosed with cancer in 2021, with projections reaching 185,000 by 2030.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
#What is the Projected CAGR for the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size from 2025 to 2034?
The ribose-nucleic acid (RNA)-based therapeutics market has shown strong growth in recent years. It will increase from $15.79 billion in 2024 to $17.26 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. This growth is due to increased investment, the discovery of RNA interference (RNAi), clinical successes with antisense oligonucleotides (ASOs), regulatory support, and industry collaborations.
The ribose-nucleic acid (RNA)-based therapeutics market is projected to reach $24.26 billion by 2029, growing at a CAGR of 8.9%. Contributing factors include expanding indications, market demand, AI and machine learning integration, and emerging applications in rare diseases. Trends include advanced delivery systems, multi-target RNA therapeutics, and commercialization growth.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
What Are the Latest Innovations Influencing theRibose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major companies in the RNA-based therapeutics market are developing mRNA-based booster vaccines to improve immunization effectiveness. In June 2023, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical company, launched GEMCOVAC-OM, India’s first mRNA booster vaccine targeting the Omicron variant of COVID-19. This vaccine boosts immunity and offers enhanced protection against the evolving virus.
Who Are the Major Industry Players Accelerating Growth in theRibose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Are Driving Growth and Industry Transformations?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented –
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theRibose-Nucleic Acid (RNA)-Based Therapeutics Market?# Market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market 2025, By The Business Research Company:
Nucleic Acid Based Gene Therapy Global Market Report 2024
Nucleic Acid Labeling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Space Militarization Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/space-militarization-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
